<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00766129</url>
  </required_header>
  <id_info>
    <org_study_id>N403 2786 33</org_study_id>
    <nct_id>NCT00766129</nct_id>
  </id_info>
  <brief_title>Comparison of Safety and Efficacy of Two Different Drug Eluting Stents Implanted Into Saphenous Vein Grafts</brief_title>
  <official_title>Comparison of Safety and Efficacy of Drug Eluting Stents : TAXUS (Boston Scientific) vs. LUC-Chopin (Balton, Poland) Implanted Into Saphenous Vein Grafts. Study With Serial Intravascular Ultrasounds.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Cardiology, Warsaw, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Cardiology, Warsaw, Poland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Drug eluting stents significantly reduced the rate of in-stent restenosis in coronary
      arteries. There are several kinds of DES i.e. eluting the drug either from stable or
      biodegradable polymer. The type of the polymer may impact the clinical outcome. The aim of
      our study was to compare safety and efficacy of implantation of two different types of stents
      eluting paclitaxel from stable vs biodegradable polymer (TAXUS stent vs LUC-CHOPIN stent)
      into coronary artery by-pass graft.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2008</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neointima hyperplasia volume by Intravascular Ultrasound</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographic late loss</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Stenosis in Saphenous Vein Graft, Drug Eluting Stent</condition>
  <arm_group>
    <arm_group_label>T</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of Taxus stent into saphenous vein graft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of Luc-Chopin stent into saphenous vein graft</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Taxus stent implantation</intervention_name>
    <description>Patients will be treated with implantation of Taxus stent</description>
    <arm_group_label>T</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Luc-Chopin stent</intervention_name>
    <description>Patients will be treated will implantation of Luc-Chopin stent</description>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Atherosclerotic lesion in saphenous vein grafts causing angiographic stenosis â‰¥70%

          2. Stable coronary artery disease or non ST segment elevation acute coronary syndrome

          3. Reference segment diameter in range of 2.5-4.5mm

        Exclusion Criteria:

          1. Cardiogenic shock

          2. Contraindications to prolonged dual antiplatelet therapy

          3. Female of child birth potential unless on effective contraception

          4. Other medical condition that may limit survival
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam R Witkowski, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Cardiology, Warsaw, Poland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2008</study_first_submitted>
  <study_first_submitted_qc>October 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2008</study_first_posted>
  <last_update_submitted>July 4, 2011</last_update_submitted>
  <last_update_submitted_qc>July 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Adam Witkowski</name_title>
    <organization>Institute of Cardiology,Warsaw,Poland</organization>
  </responsible_party>
  <keyword>saphenous vein graft, TAXUS stent, Chopin stent</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

